Skip to main content

Table 2 Baseline prevalence rate of CVD in different stages of CKD in C-STRIDE Study (Nov 2011–Mar 2016)

From: Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Variable   eGFR (ml/min/1.73 m2) P for trend
Total >60 45–60 30–45 15–30
(n = 3168) (n = 975) (n = 497) (n = 769) (n = 927)
MI 64 (20.58) 6 (0.62) 9 (1.81) 22 (2.86) 27 (2.91) 0.001
CHF 28 (9.00) 3 (0.31) 5 (1.01) 9 (1.17) 11 (1.19) 0.14
Cerebrovascular disease 215 (69.13) 22 (2.26) 44 (8.85) 58 (7.54) 91 (9.82) <0.001
PAD 50 (10.08) 3 (0.31) 8 (1.61) 13 (1.69) 26 (2.81) <0.001
Total CVD 311 (9.82) 31 (3.18) 59 (11.87) 86 (11.18) 135 (14.56)  
  1. Categorical data are presented as numbers (n) of patients and percentages. MI myocardial infarction, CHF congestive heart failure, PAD peripheral arterial disease